TY - JOUR T1 - The German Corona Consensus Dataset (GECCO): A standardized dataset for COVID-19 research JF - medRxiv DO - 10.1101/2020.07.27.20162636 SP - 2020.07.27.20162636 AU - Julian Sass AU - Alexander Bartschke AU - Moritz Lehne AU - Andrea Essenwanger AU - Eugenia Rinaldi AU - Stefanie Rudolph AU - Kai U. Heitmann AU - Jörg J. Vehreschild AU - Christof von Kalle AU - Sylvia Thun Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/29/2020.07.27.20162636.abstract N2 - Background The current COVID-19 pandemic has led to a surge of research activity. While this research provides important insights, the multitude of studies results in an increasing segmentation of information. To ensure comparability across projects and institutions, standard datasets are needed. Here, we introduce the “German Corona Consensus Dataset” (GECCO), a uniform dataset that uses international terminologies and health IT standards to improve interoperability of COVID-19 data.Methods Based on previous work (e.g., the ISARIC-WHO COVID-19 case report form) and in coordination with experts from university hospitals, professional associations and research initiatives, data elements relevant for COVID-19 research were collected, prioritized and consolidated into a compact core dataset. The dataset was mapped to international terminologies, and the Fast Healthcare Interoperability Resources (FHIR) standard was used to define interoperable, machine-readable data formats.Results A core dataset consisting of 81 data elements with 281 response options was defined, including information about, for example, demography, anamnesis, symptoms, therapy, medications or laboratory values of COVID-19 patients. Data elements and response options were mapped to SNOMED CT, LOINC, UCUM, ICD-10-GM and ATC, and FHIR profiles for interoperable data exchange were defined.Conclusion GECCO provides a compact, interoperable dataset that can help to make COVID-19 research data more comparable across studies and institutions. The dataset will be further refined in the future by adding domain-specific extension modules for more specialized use cases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData elements, response options, value sets and FHIR profiles of the GECCO dataset are publicly available on ART-DECOR and Simplifier (see links). https://art-decor.org/art-decor/decor-datasets--covid19f- https://simplifier.net/ForschungsnetzCovid-19 ER -